"Vulvar Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological processes of the VULVA.
| Descriptor ID |
D014845
|
| MeSH Number(s) |
C13.351.500.944
|
| Concept/Terms |
Vulvar Diseases- Vulvar Diseases
- Disease, Vulvar
- Diseases, Vulvar
- Vulvar Disease
|
Below are MeSH descriptors whose meaning is more general than "Vulvar Diseases".
Below are MeSH descriptors whose meaning is more specific than "Vulvar Diseases".
This graph shows the total number of publications written about "Vulvar Diseases" by people in this website by year, and whether "Vulvar Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 9 | 0 | 9 |
| 2019 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Vulvar Diseases" by people in Profiles.
-
Ulcus vulvae acutum and SARS-CoV-2: an aetiological role? J Eur Acad Dermatol Venereol. 2021 Oct; 35(10):e647-e649.
-
Mortality of a postpartum woman presented with massive vulvar edema in association with Covid-19: a case report with clinical and radiological findings. BMC Infect Dis. 2021 Jul 13; 21(1):678.
-
Vulvar Aphthous Ulcer in an Adolescent With COVID-19. J Pediatr Adolesc Gynecol. 2021 Jun; 34(3):418-420.
-
Ospemifene plus fractional CO2 laser: a powerful strategy to treat postmenopausal vulvar pain. Gynecol Endocrinol. 2020 May; 36(5):431-435.
-
The effect of vulvovaginal atrophy on women's quality of life from an Italian cohort of the EVES study. J Obstet Gynaecol. 2020 May; 40(4):512-519.
-
Mycosis fungoides presenting as vulvar plaques. J Eur Acad Dermatol Venereol. 2019 Apr; 33(4):e172-e174.
-
Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part II: Evaluation of tolerability and safety. Maturitas. 2019 Mar; 121:93-100.
-
Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part I: Evaluation of efficacy. Maturitas. 2019 Mar; 121:86-92.
-
Primavera: A new therapeutical approach to vulvo-vaginal atrophy. Dermatol Ther. 2018 11; 31(6):e12678.
-
Segmental Hailey-Hailey disease of the vulva. Pediatr Dermatol. 2018 Nov; 35(6):e398-e399.